Home / Pyxis Oncology, Inc. (PYXS)

Updated: 2026-03-17 00:38 UTC · Last close: 1.67 (+8.44%)

Pyxis Oncology, Inc. (PYXS) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.

The latest close for Pyxis Oncology, Inc. (PYXS) came in at 1.67 (+8.44%). The stock is back above its 50-day average but still below the 200-day average, which suggests improving short-term tone within a still-repairing long-term structure. 20-day momentum is notably strong at +28.46%; price is trading in the lower part of its roughly 52-week range (0.88–5.34); and ATR14 volatility is elevated at roughly 6.21% of price. RSI(14) reads 58.8, suggesting buyers still hold the momentum advantage. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram is positive and expanding, pointing to improving upside momentum. Recent trading volume is running well above its 20-day average, which suggests strong participation behind the latest price moves. The chart is currently flagging Double top. Near-term structure is defined by support at 1.43 and resistance at 1.72. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Revenue: 2.82M · Net income: -61.52M · EPS (basic): -0.99. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.

OPEN FULL INTERACTIVE ANALYSIS

Note: This is an algorithmic technical snapshot (not financial advice).

PYXS Chart